Stock Weekly: Medicenna Therapeutics (MDNA:CAD5.47) climbs 5.2% on robust volume
CANADIAN WEEKLY STOCK REPORT
Medicenna Therapeutics Corp. (TSX:MDNA), Canada's 14th largest Biotechnology company by market cap, has lifted 27.0c (or 5.2%) in the past week to close at CAD5.47, ending a three-week streak of losses. Compared with the S&P/TSX 60 Index which fell 3.7 points (or 0.3%) in the week, this represented a relative price increase of 5.5%.
In the past week the market cap has risen by CAD13.2 million ($10.4 million) to CAD267.6 million.
This has been prop...